Obstacles to diagnosis and treatment of Lyme disease in the USA: A qualitative study

Annemarie G. Hirsch, Rachel J. Herman, Alison Rebman, Katherine A. Moon, John Aucott, Christopher David Heaney, Brian S Schwartz

Research output: Contribution to journalArticle

Abstract

Objective For many individuals with Lyme disease, prompt treatment leads to rapid resolution of infection. However, severe complications can occur if treatment is delayed. Our objective was to identify themes around belated diagnosis or treatment of Lyme disease using the General Model of Total Patient Delay (GMTPD). Design We conducted a qualitative interview study using indepth telephone interviews. Setting Participants were patients from a large, integrated health system in the state of Pennsylvania, USA. Participants There were 26 participants. Participants had to have a diagnosis of Lyme disease between 2014 and 2017 and a positive IgG western blot. We used a stratified purposeful sampling design to identify patients with and without late Lyme disease manifestations. To ensure variation in care experiences, we oversampled patients diagnosed outside of primary care. Outcome measures We asked participants about their experience from first Lyme disease symptoms to treatment. We applied an iterative coding process to identify key themes and then synthesised codes into higher order codes representing the GMTPD stages: appraisal delay (symptom to recognition of illness); illness delay (inferring illness to deciding to seek help); behavioural delay (deciding to seek help to the act of seeking help); scheduling delay (seeking help to attending an appointment); and treatment delay (attending appointment to treatment). Results Appraisal delay themes included symptom misattribution, intermittent symptoms and misperceptions about the necessity of a bull's-eye rash. Health insurance status was a driver of illness and behavioural delays. Scheduling delay was not noted by participants, in part, because 10 of the 26 patients went to urgent care or emergency department settings. Misdiagnoses were more common in these settings, contributing to treatment delay. Conclusion Our study identified potentially modifiable risk factors for belated treatment. Targeting these risk factors may minimise time to treatment and reduce the occurrence of preventable complications.

Original languageEnglish (US)
Article numbere021367
JournalBMJ Open
Volume8
Issue number6
DOIs
StatePublished - Jun 1 2018

Fingerprint

Lyme Disease
Therapeutics
Appointments and Schedules
Interviews
Insurance Coverage
Health Insurance
Ambulatory Care
Exanthema
Diagnostic Errors
Health Status
Hospital Emergency Service
Primary Health Care
Immunoglobulin G
Western Blotting
Outcome Assessment (Health Care)
Health

Keywords

  • Lyme disease
  • Patient delay
  • Qualitative research
  • Social medicine

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Obstacles to diagnosis and treatment of Lyme disease in the USA : A qualitative study. / Hirsch, Annemarie G.; Herman, Rachel J.; Rebman, Alison; Moon, Katherine A.; Aucott, John; Heaney, Christopher David; Schwartz, Brian S.

In: BMJ Open, Vol. 8, No. 6, e021367, 01.06.2018.

Research output: Contribution to journalArticle

Hirsch, Annemarie G. ; Herman, Rachel J. ; Rebman, Alison ; Moon, Katherine A. ; Aucott, John ; Heaney, Christopher David ; Schwartz, Brian S. / Obstacles to diagnosis and treatment of Lyme disease in the USA : A qualitative study. In: BMJ Open. 2018 ; Vol. 8, No. 6.
@article{b7d68b4d634f4cafbb07db481a3e945e,
title = "Obstacles to diagnosis and treatment of Lyme disease in the USA: A qualitative study",
abstract = "Objective For many individuals with Lyme disease, prompt treatment leads to rapid resolution of infection. However, severe complications can occur if treatment is delayed. Our objective was to identify themes around belated diagnosis or treatment of Lyme disease using the General Model of Total Patient Delay (GMTPD). Design We conducted a qualitative interview study using indepth telephone interviews. Setting Participants were patients from a large, integrated health system in the state of Pennsylvania, USA. Participants There were 26 participants. Participants had to have a diagnosis of Lyme disease between 2014 and 2017 and a positive IgG western blot. We used a stratified purposeful sampling design to identify patients with and without late Lyme disease manifestations. To ensure variation in care experiences, we oversampled patients diagnosed outside of primary care. Outcome measures We asked participants about their experience from first Lyme disease symptoms to treatment. We applied an iterative coding process to identify key themes and then synthesised codes into higher order codes representing the GMTPD stages: appraisal delay (symptom to recognition of illness); illness delay (inferring illness to deciding to seek help); behavioural delay (deciding to seek help to the act of seeking help); scheduling delay (seeking help to attending an appointment); and treatment delay (attending appointment to treatment). Results Appraisal delay themes included symptom misattribution, intermittent symptoms and misperceptions about the necessity of a bull's-eye rash. Health insurance status was a driver of illness and behavioural delays. Scheduling delay was not noted by participants, in part, because 10 of the 26 patients went to urgent care or emergency department settings. Misdiagnoses were more common in these settings, contributing to treatment delay. Conclusion Our study identified potentially modifiable risk factors for belated treatment. Targeting these risk factors may minimise time to treatment and reduce the occurrence of preventable complications.",
keywords = "Lyme disease, Patient delay, Qualitative research, Social medicine",
author = "Hirsch, {Annemarie G.} and Herman, {Rachel J.} and Alison Rebman and Moon, {Katherine A.} and John Aucott and Heaney, {Christopher David} and Schwartz, {Brian S}",
year = "2018",
month = "6",
day = "1",
doi = "10.1136/bmjopen-2017-021367",
language = "English (US)",
volume = "8",
journal = "BMJ Open",
issn = "2044-6055",
publisher = "BMJ Publishing Group",
number = "6",

}

TY - JOUR

T1 - Obstacles to diagnosis and treatment of Lyme disease in the USA

T2 - A qualitative study

AU - Hirsch, Annemarie G.

AU - Herman, Rachel J.

AU - Rebman, Alison

AU - Moon, Katherine A.

AU - Aucott, John

AU - Heaney, Christopher David

AU - Schwartz, Brian S

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Objective For many individuals with Lyme disease, prompt treatment leads to rapid resolution of infection. However, severe complications can occur if treatment is delayed. Our objective was to identify themes around belated diagnosis or treatment of Lyme disease using the General Model of Total Patient Delay (GMTPD). Design We conducted a qualitative interview study using indepth telephone interviews. Setting Participants were patients from a large, integrated health system in the state of Pennsylvania, USA. Participants There were 26 participants. Participants had to have a diagnosis of Lyme disease between 2014 and 2017 and a positive IgG western blot. We used a stratified purposeful sampling design to identify patients with and without late Lyme disease manifestations. To ensure variation in care experiences, we oversampled patients diagnosed outside of primary care. Outcome measures We asked participants about their experience from first Lyme disease symptoms to treatment. We applied an iterative coding process to identify key themes and then synthesised codes into higher order codes representing the GMTPD stages: appraisal delay (symptom to recognition of illness); illness delay (inferring illness to deciding to seek help); behavioural delay (deciding to seek help to the act of seeking help); scheduling delay (seeking help to attending an appointment); and treatment delay (attending appointment to treatment). Results Appraisal delay themes included symptom misattribution, intermittent symptoms and misperceptions about the necessity of a bull's-eye rash. Health insurance status was a driver of illness and behavioural delays. Scheduling delay was not noted by participants, in part, because 10 of the 26 patients went to urgent care or emergency department settings. Misdiagnoses were more common in these settings, contributing to treatment delay. Conclusion Our study identified potentially modifiable risk factors for belated treatment. Targeting these risk factors may minimise time to treatment and reduce the occurrence of preventable complications.

AB - Objective For many individuals with Lyme disease, prompt treatment leads to rapid resolution of infection. However, severe complications can occur if treatment is delayed. Our objective was to identify themes around belated diagnosis or treatment of Lyme disease using the General Model of Total Patient Delay (GMTPD). Design We conducted a qualitative interview study using indepth telephone interviews. Setting Participants were patients from a large, integrated health system in the state of Pennsylvania, USA. Participants There were 26 participants. Participants had to have a diagnosis of Lyme disease between 2014 and 2017 and a positive IgG western blot. We used a stratified purposeful sampling design to identify patients with and without late Lyme disease manifestations. To ensure variation in care experiences, we oversampled patients diagnosed outside of primary care. Outcome measures We asked participants about their experience from first Lyme disease symptoms to treatment. We applied an iterative coding process to identify key themes and then synthesised codes into higher order codes representing the GMTPD stages: appraisal delay (symptom to recognition of illness); illness delay (inferring illness to deciding to seek help); behavioural delay (deciding to seek help to the act of seeking help); scheduling delay (seeking help to attending an appointment); and treatment delay (attending appointment to treatment). Results Appraisal delay themes included symptom misattribution, intermittent symptoms and misperceptions about the necessity of a bull's-eye rash. Health insurance status was a driver of illness and behavioural delays. Scheduling delay was not noted by participants, in part, because 10 of the 26 patients went to urgent care or emergency department settings. Misdiagnoses were more common in these settings, contributing to treatment delay. Conclusion Our study identified potentially modifiable risk factors for belated treatment. Targeting these risk factors may minimise time to treatment and reduce the occurrence of preventable complications.

KW - Lyme disease

KW - Patient delay

KW - Qualitative research

KW - Social medicine

UR - http://www.scopus.com/inward/record.url?scp=85053161027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053161027&partnerID=8YFLogxK

U2 - 10.1136/bmjopen-2017-021367

DO - 10.1136/bmjopen-2017-021367

M3 - Article

C2 - 29895655

AN - SCOPUS:85053161027

VL - 8

JO - BMJ Open

JF - BMJ Open

SN - 2044-6055

IS - 6

M1 - e021367

ER -